Nearly forty years ago, Dr. Peter Silverstone was a young MD who took up a new position in psychopharmacology research at Oxford University. Since then, the field has bloomed into a spectrum of possibilities that includes the use of psychedelics as a treatment for depression, addiction, PTSD, grief, and anxiety.
And Dr. Silverstone has gone on to lead ground-breaking research into things like amphetamine interaction with the brain, mental health’s impact on physical health, psychedelic use in psychotherapy, and to lead award-winning treatment breakthroughs in mental healththerapy programs.
The Promise of Psychedelics is for you—if you or someone you know has not received successful treatment despite trying several mental health therapy programs and medication. You are not alone: one in five adults at any one time suffer mental health issues that impact their functioning.
Often, medication alone doesn’t work, especially for conditions like PTSD, grief, depression, anxiety, addictions, or personality issues. Despite the best efforts of clinicians, medications or other psychological treatments are usually only partially effective. Sometimes, treatments don’t help at all.
Psychedelics such as psilocybin, ketamine, MDMA, cannabinoids, and LSD can cause profound, intense changes—not only in what we experience but how we think, how we feel, and what we do.